The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Borrower

R•••••••• G••••• I••

Drug Discovery & Developmentgroup grade Aon a schedule nowsponsor O•••• F••• M••••••••• L•• carried
Also written as: Inc. and
Principal held
at least $57.3M
sum of BDC pieces, a lower bound
Fair value
$58.3M
100c on cost, debt pieces
Unfunded
n/a
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Oct 1, 2027
$57.3M inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2026
Events
2
dated, non-routine
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
FacilityHeldOn costPricingMaturityBDCs
first lien term loan first lienat least $57.3M100cS+175 bp
PIK 1.50%
Oct 1, 20271
Lenders
every BDC piece at the latest quarter end
BDCInstrumentPrincipalFair valueRate
H••••••• C••••••• I•••term loan first lien
S••••• S••••••, O•••••• 2027, P•••• + 1.75%, F•••• rate 8.50%, Cap rate 9.00%, PIK I••••••
$57.3M$58.3M
100c
S+175 bp
PIK 1.50%
Through time
the borrower's pieces summed across BDCs, every quarter end
Quarter endBDCsPrincipal heldFair valueOn costPIK pieces
Jun 30, 20261$57.3M$58.3M100c1
Mar 31, 20261$57.0M$58.0M100c1
Dec 31, 20251$64.8M$66.6M100c2
Sep 30, 20251$32.3M$33.3M101c1
Jun 30, 20251$32.1M$34.0M104c1
Mar 31, 20251$32.0M$33.9M104c1
Dec 31, 20241$31.9M$33.7M104c1
Sep 30, 20241$31.8M$33.8M105c1
Jun 30, 20241$31.6M$33.4M105c1
Mar 31, 20241$31.5M$33.0M104c1
Dec 31, 20231$94.2M$98.1M104c3
Sep 30, 20231$21.0M$21.5M102c1
Jun 30, 20231$20.9M$21.2M102c1
Mar 31, 20231$20.8M$20.8M100c1
Dec 31, 20221$20.8M$20.7M100c1
What changed
Every change including routine ones
Identity
Group key
REPLIMUNEderivedthe codename stem after legal suffixes and deal words
Spellings
1 across 1 BDCderived
Industry
Drug Discovery & Developmentreportedas one filer wrote it